OrderlyMeds

What it is

Licensed providers prescribe online and medications are shipped from partner compounding pharmacies.

Pricing is presented as all-inclusive of provider visits, medication and messaging.

Compounded NAD+ and sermorelin are offered to existing GLP-1 patients.

Prescribes: Compounded tirzepatide-based GLP-1 products (not FDA-approved) and brand-name Zepbound and Wegovy.

What it costs

Insurance: Insurance not required.

Prices change often. Check orderlymeds.com before you sign up.

By the numbers

• Trustpilot 3.5/5 from 655 reviews (28% 1-star; checked 2026-10-15).4
• BBB: F; not BBB Accredited; 188 complaints in the last 3 years (checked 2026-10-15).5

Pros and cons

What users say

Common themes in public posts on Reddit, Trustpilot, the Better Business Bureau and app stores, summarised and linked. Individual experiences vary.

• Some reviewers praise supportive staff, easy ordering and affordable pricing.3
• Many one-star reviews cite late or warm deliveries, refund denials and difficulty reaching a live person.3
• OrderlyMeds draws a large volume of Reddit posts; in April 2026 several members posted photos of vials they said contained particles and said Orderly would not replace them, while replies suggested some vials looked frozen and pointed to the dispensing pharmacy.89
• Members describe multi-week shipping delays and payment disputes in 2026, while others in the same threads say they have used Orderly for about a year without problems and received a credit when an order was late.101112
• Its lower multi-month prices (for example $499 for three months in May 2025) draw interest, and some members say its compounded tirzepatide works well for them.13
• Trustpilot reviewers (28% one-star) praise kind staff, check-ins and pricing; complaints cite late or failed deliveries, warm medication and refused refunds for dispensed medication.4

Records we found

Official and court records we found in public sources as of October 15, 2026. This is not a live or complete record; check fda.gov, ftc.gov and court sites for the latest.

1. Jun 2026
   FDA

   FDA sent a warning letter to OrderlyMeds LLC stating that its logo on pictured labels suggested it is the compounder and that describing products as from an "FDA-licensed pharmacy" was false or misleading, rendering its compounded semaglutide and tirzepatide misbranded.2